1. Home
  2. List
Reference Patent

Reference - List

  • 7 Hits
  • Search Condition : Filter (MeSH = Carcinoma, Pancreatic Ductal / drug therapy*)
Species Resource Title
Human and Animal Cells PANC-1(RCB2095) Subtypes in pancreatic ductal adenocarcinoma based on niche factor dependency show distinct drug treatment responses.
Human and Animal Cells PK-1(RCB1972) , KLM-1(RCB2138) Avarol induces apoptosis in pancreatic ductal adenocarcinoma cells by activating PERK-eIF2α-CHOP signaling.
DNA material CSII-CMV-MCS-IRES2-Bsd (RDB04385) , pCMV-VSV-G-RSV-Rev (RDB04393) , pCAG-HIVgp (RDB04394) DPYD, down-regulated by the potentially chemopreventive agent luteolin, interacts with STAT3 in pancreatic cancer.
Human and Animal Cells PK-8(RCB2700) , KLM-1(RCB2138) Cancer-Specific Targeting of Taurine-Upregulated Gene 1 Enhances the Effects of Chemotherapy in Pancreatic Cancer.
Human and Animal Cells PANC-1(RCB2095) Inhibition of ERK1/2 in cancer-associated pancreatic stellate cells suppresses cancer-stromal interaction and metastasis.
Human and Animal Cells KP4(RCB1005) Onartuzumab (MetMAb): using nonclinical pharmacokinetic and concentration-effect data to support clinical development.
Human and Animal Cells PK-45P(RCB2141) , PK-1(RCB1972) Chemotherapy-Derived Inflammatory Responses Accelerate the Formation of Immunosuppressive Myeloid Cells in the Tissue Microenvironment of Human Pancreatic Cancer.